KBTBD3
Kelch repeat and BTB domain-containing protein 3
Also known as: BKLHD3, KBTB3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NAB2
- Gene
- KBTBD3
- Ensembl
- ENSG00000182359
- Chromosome
- 11
- Canonical length
- 612 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable ubiquitin-like ligase-substrate adaptor activity. Predicted to be involved in proteasome-mediated ubiquitin-dependent protein catabolic process. Predicted to be located in nucleus. Predicted to be part of Cul3-RING ubiquitin ligase complex. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
612 residues, UniProt reviewed canonical sequence.
>Q8NAB2|KBTBD3
1 MELAMDNSYA FNQRSTCNGI PSEKKNNFLV SEDHGQKILS VLQNFREQNV FYDFKIIMKD
61 EIIPCHRCVL AACSDFFRAM FEVNMKERDD GSVTITNLSS KAVKAFLDYA YTGKTKITDD
121 NVEMFFQLSS FLQVSFLSKA CSDFLIKSIN LVNCLQLLSI SDSYGSTSLF DHALHFVQHH
181 FSLLFKSSDF LEMNFGVLQK CLESDELNVP EEEMVLKVVL SWTKHNLESR QKYLPHLIEK
241 VRLHQLSEET LQDCLFNEES LLKSTNCFDI IMDAIKCVQG SGGLFPDARP STTEKYIFIH
301 KTEENGENQY TFCYNIKSDS WKILPQSHLI DLPGSSLSSY GEKIFLTGGC KGKCCRTVRL
361 HIAESYHDAT DQTWCYCPVK NDFFLVSTMK TPRTMHTSVM ALDRLFVIGG KTRGSRDIKS
421 LLDVESYNPL SKEWISVSPL PRGIYYPEAS TCQNVIYVLG SEVEITDAFN PSLDCFFKYN
481 ATTDQWSELV AEFGQFFHAT LIKAVPVNCT LYICDLSTYK VYSFCPDTCV WKGEGSFECA
541 GFNAGAIGIE DKIYILGGDY APDEITDEVQ VYHSNRSEWE EVSPMPRALT EFYCQVIQFN
601 KYRDPWFSNL CALocalizationUniProt · AlphaFold · HPA
Whether an antibody against KBTBD3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 9.6 nTPM
Expression across tissuesHPA
Tissue
- retina: 9.6 nTPM
- choroid plexus: 5.8 nTPM
- spinal cord: 5.2 nTPM
- epididymis: 4.1 nTPM
- kidney: 3.9 nTPM
- cerebellum: 3.7 nTPM
Single-cell type
- early spermatids: 115 nCPM
- late primary spermatocytes: 90 nCPM
- epididymal principal cells: 49 nCPM
- oligodendrocytes: 48 nCPM
- gastric chief cells: 42 nCPM
- corticotrophs: 40 nCPM
Immune cell
- basophil: 31 nTPM
- eosinophil: 19 nTPM
- T-reg: 16 nTPM
- NK-cell: 15 nTPM
- memory CD4 T-cell: 14 nTPM
- memory B-cell: 13 nTPM
Brain region
- cerebellum: 22 nTPM
- white matter: 20 nTPM
- pons: 16 nTPM
- cerebral cortex: 15 nTPM
- thalamus: 14 nTPM
- medulla oblongata: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.88
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.84
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- BTB/POZ domain
- Kelch repeat type 1
- SKP1/BTB/POZ domain superfamily
- BTB/Kelch-associated
- Kelch-type beta-propeller
- BTB-kelch protein
- BTB/POZ domain
- Kelch motif
- BTB And C-terminal Kelch
- Kelch repeat and BTB domain-containing protein 3, BTB/POZ domain
- Kelch repeat and BTB domain-containing protein 3, BACK domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KBTBD3 as an antibody target. Whether an autoantibody or antibody against KBTBD3 could matter depends on whether native KBTBD3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KBTBD3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label KBTBD3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...